Evaluation of Natural Human Interferon Alpha Lozenges in the Treatment of Chronic Cough in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF).
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2012
At a glance
- Drugs Interferon alpha (Primary)
- Indications Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 23 Apr 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 23 Apr 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Apr 2012 Actual patient number is 1 according to ClinicalTrials.gov.